Lenacapavir's biannual administration may reduce stigma and improve adherence to HIV prevention strategies. New data from the PURPOSE 2 trial continue to show the efficacy of lenacapavir in HIV ...
You’ll gain insights into the latest advancements in HIV treatment and prevention, including innovations in long-acting formulations. The session will also cover recent progress in STI treatment and ...